RIFAXIMIN IMPROVES BOTH ABDOMINAL PAIN AND BLOATING IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A COMPOSITE ENDPOINT ANALYSIS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

被引：0
|
作者：
Lacy, Brian E.
Chang, Lin
Rao, Satish S.
Heimanson, Zeev
Sayuk, Gregory S.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fr255
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [1] EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Lacy, Brian E.
    Pimentel, Mark
    Chang, Christopher
    Heimanson, Zeev
    Lembo, Anthony J.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S498 - S499
  • [2] Rifaximin Improves Both Fecal Urgency and Stool Consistency in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D): A Composite Endpoint Analysis of Two Randomized, Phase 3 Trials
    Cash, Brooks D.
    Staller, Kyle
    Neshatian, Leila
    Allen, Christopher
    Heimanson, Zeev
    Rezaie, Ali
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S384 - S385
  • [3] Association between symptoms in irritable bowel syndrome with diarrhea (IBS-D): A pooled correlation and tricomposite endpoint analysis of two phase 3, randomized, placebo-controlled, rifaximin trials
    Staller, K.
    Lacy, B. E.
    Sayuk, G. S.
    Rao, S. S. C.
    Karsan, H. A.
    Neshatiana, L.
    Lunsford, T. N.
    Allen, C.
    Heimanson, Z.
    Brenner, D. M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
  • [4] Rifaximin for Irritable Bowel Syndrome A Meta-Analysis of Randomized Placebo-Controlled Trials
    Li, Jun
    Zhu, Wenhua
    Liu, Wenhui
    Wu, Yingqiao
    Wu, Benyan
    [J]. MEDICINE, 2016, 95 (04)
  • [5] PLECANATIDE IMPROVES ABDOMINAL PAIN, BLOATING, AND STRAINING SYMPTOMS IN ADULTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): A NEW COMPOSITE ENDPOINT ANALYSIS OF TWO RANDOMIZED, PHASE 3 TRIALS
    Brenner, Darren M.
    Poppers, David
    Laitman, Adam P.
    Allen, Christopher
    Shah, Eric D.
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1058 - S1059
  • [6] Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
    Lembo, Anthony
    Rao, Satish S. C.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00144
  • [7] RIFAXIMIN SIGNIFICANTLY IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA: A POOLED ANALYSIS OF THREE PHASE 3 TRIALS
    Schoenfeld, Philip S.
    Brenner, Darren M.
    Pichetshote, Nipaporn
    Heimanson, Zeev
    Lacy, Brian E.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S281 - S281
  • [8] A NEW TRISYMPTOM COMPOSITE ENDPOINT TO EVALUATE THE EFFICACY OF RIFAXIMIN FOR THE MULTIPLE SYMPTOMS OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D): A POOLED ANALYSIS OF TWO RANDOMIZED, PHASE 3 TRIALS
    Lacy, Brian E.
    Sayuk, Gregory S.
    Karsan, Hetal A.
    Allen, Christopher
    Heimanson, Zeev
    Brenner, Darren M.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S756 - S757
  • [9] The fragility of randomized placebo-controlled trials for irritable bowel syndrome
    Williams, MaryJane O.
    Sedarous, Mary
    Dennis, Brittany
    Dlamini, Vanessa
    Nwaiwu, Obioma
    Nguyen, Linda
    Okafor, Philip N.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (08):
  • [10] Safety and Tolerability of Rifaximin in the Treatment of Irritable Bowel Syndrome (IBS): A Pooled Analysis of 4 Randomized, Placebo-Controlled Trials
    Lembo, Anthony J.
    Pimentel, Mark
    Wolf, Ray
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
12345